These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36637715)

  • 1.
    Weng R; Ren S; Su J; Ni W; Yang C; Gao X; Xiao W; Zhang X; Jiang H; Guan Y; Huang Q; Gu Y
    Brain Imaging Behav; 2023 Apr; 17(2):185-199. PubMed ID: 36637715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of Cognitive Impairment in Adult Moyamoya Disease: A Classifier Based on High-Order Resting-State Functional Connectivity Network.
    Lei Y; Chen X; Su JB; Zhang X; Yang H; Gao XJ; Ni W; Chen L; Yu JH; Gu YX; Mao Y
    Front Neural Circuits; 2020; 14():603208. PubMed ID: 33408614
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer's disease and vascular cognitive impairment].
    Emelin AY; Odinak MM; Lobzin VY; Kolmakova KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4. Vyp. 2):17-24. PubMed ID: 38696147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial spin labeling versus
    Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
    Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG-PET correlates of cognitive impairment in ALS.
    Canosa A; Pagani M; Cistaro A; Montuschi A; Iazzolino B; Fania P; Cammarosano S; Ilardi A; Moglia C; Calvo A; Chiò A
    Neurology; 2016 Jan; 86(1):44-9. PubMed ID: 26590270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Brain Glucose Metabolism Assessed by
    Su J; Huang Q; Ren S; Xie F; Zhai Y; Guan Y; Liu J; Hua F
    Neuroscience; 2019 Oct; 417():35-44. PubMed ID: 31394195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
    Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH
    Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19.
    Ferrucci R; Cuffaro L; Capozza A; Rosci C; Maiorana N; Groppo E; Reitano MR; Poletti B; Ticozzi N; Tagliabue L; Silani V; Priori A
    J Neurol; 2023 Apr; 270(4):1823-1834. PubMed ID: 36692636
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yuan F; Yu J; Liao G; Li J; Long T; Li Y; Chen D; Dai Q; Zhu X; Hu S; Qian Z
    Addict Biol; 2021 Sep; 26(5):e13043. PubMed ID: 33908137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
    Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
    Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
    Jiménez-Bonilla JF; Banzo I; De Arcocha-Torres M; Quirce R; Martínez-Rodríguez I; Lavado-Pérez C; Bravo-Ferrer Z; Rodríguez-Rodríguez E; Sánchez-Juan P; Carril JM
    Nucl Med Commun; 2016 Nov; 37(11):1189-96. PubMed ID: 27341411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous brain activity in adult patients with moyamoya disease: a resting-state fMRI study.
    Lei Y; Li Y; Ni W; Jiang H; Yang Z; Guo Q; Gu Y; Mao Y
    Brain Res; 2014 Feb; 1546():27-33. PubMed ID: 24380677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
    J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment.
    Song IU; Choi EK; Oh JK; Chung YA; Chung SW
    Acta Radiol; 2016 Jan; 57(1):90-7. PubMed ID: 25538106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain
    Van Der Gucht A; Aoun Sebaiti M; Guedj E; Aouizerate J; Yara S; Gherardi RK; Evangelista E; Chalaye J; Cottereau AS; Verger A; Bachoud-Levi AC; Abulizi M; Itti E; Authier FJ
    J Nucl Med; 2017 Mar; 58(3):492-498. PubMed ID: 27765861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
    Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
    Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.
    Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S
    Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.